< Home < Back

Sudeep Pharma - Quaterly Results

Date: 29-10-2026
The turnover is pegged at Rs. 1374.13 millions for the September 2026 quarter. The mentioned figure indicates a rise of about 56.36% as against Rs. 878.82 millions during the year-ago period.The company has announced a 42.35% increase in its profits to Rs . 423.38  millions for the  quarter ended September 2026 compared to Rs. 297.42 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 621.21 millions from 437.06 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 1374.13 878.82 56.36 2430.96 1680.56 44.65 3385.05 3567.32 -5.11
Other Income 105.09 128.27 -18.07 203.09 194.47 4.43 385.04 83.76 359.69
PBIDT 621.21 437.06 42.13 1111.16 807.18 37.66 1582.72 1403.33 12.78
Interest 22.96 20.29 13.16 40.56 34.66 17.02 60.66 48.10 26.11
PBDT 598.25 416.77 43.54 1070.60 772.52 38.59 1522.06 1355.23 12.31
Depreciation 30.54 17.73 72.25 48.80 35.21 38.60 71.10 61.17 16.23
PBT 567.71 399.04 42.27 1021.80 737.31 38.58 1450.96 1294.06 12.12
TAX 144.33 101.62 42.03 260.12 187.84 38.48 375.16 336.59 11.46
Deferred Tax 14.23 4.86 192.80 31.46 9.11 245.33 31.93 5.26 507.03
PAT 423.38 297.42 42.35 761.68 549.47 38.62 1075.80 957.47 12.36
Equity 112.95 97.23 16.17 112.95 97.23 16.17 112.95 97.23 16.17
PBIDTM(%) 45.21 49.73 -9.10 45.71 48.03 -4.83 46.76 39.34 18.86